Division of Neuropsychiatry and Neuromodulation

Clinical Services

Transcranial Magnetic Stimulation Clinic

Transcranial Magnetic Stimulation (TMS) is a non-invasive form of neuromodulation that uses magnetic pulses to stimulate neurons in targeted regions of the brain. During the procedure, a magnetic coil is placed over the targeted brain region while the patient sits comfortably, remaining awake and alert. The procedure generally lasts 3-9 minutes and consists of 36 treatment sessions. TMS is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Major Depressive Disorder (MDD) and Obsessive Compulsive Disorder (OCD). 

For more information, please visit MGH TMS Clinical Service.

Transcranial Direct Current Stimulation Clinic

Transcranial Direct Current Stimulation (tDCS) is a non-invasive form of neuromodulation that uses electrical currents to stimulate neurons in targeted regions of the brain. During the procedure, electrodes and saline-soaked sponges or electrophysiological gel are applied over the targeted brain region while the patient sits comfortable, remaining awake and alert. The procedure generally lasts 30 minutes but the number of treatment sessions can vary. tDCS is not approved by the U.S. Food and Drug Administration (FDA) for any neuropsychiatric condition. tDCS is therefore  considered off-label, meaning the treatments are clinically safe and effective yet not typically covered by health insurances.

For more information, please visit MGH tDCS Clinical Service.

Transcranial Photobiomodulation Clinic

Transcranial Photobiomodulation (tPBM) is a non-invasive form of neuromodulation that uses near infrared light to stimulate neurons in targeted regions of the brain. During the procedure, the diodes are applied over the targeted brain region while the patient sits comfortably, remaining awake and alert. The procedure generally lasts 30 minutes but the number of treatment sessions can vary. tPBM is not approved by the U.S. Food and Drug Administration (FDA) for any neuropsychiatric condition. tPBM is therefore considered off-label, meaning the treatments are clinically safe and effective yet not typically covered by health insurances.

For more information, please contact pbm@mgh.harvard.edu.

Neuropsychiatry Clinic

Stay tuned – more information will be posted soon!